NACCMENACCME
Pharmacy Learning NetworkManaged Care ConsultantCoalition of Rheumatology Educators (CORE)CME ForumCE ForumSAWCPrinceton Teleconference Series

Testing Center

Stop the Bleeding: Strategies to Achieve Hemostasis and Reduce Costs Associated with Surgical Bleeding

Stop the Bleeding: Strategies to Achieve Hemostasis and Reduce Costs Associated with Surgical Bleeding

On-Demand Video Webcast

PLN
NACCME

Sponsored by North American Center for Continuing Medical Education, LLC

Chair/Presenter

Bradley A. Boucher, PharmD, FCCP, FCCM, BCPS
Professor of Clinical Pharmacy
Associate Professor of Neurosurgery
University of Tennessee Health Science Center
Memphis, Tennessee

Presenter

Mark A. Malesker, PharmD, FCCP, BCPS
Professor of Pharmacy Practice
Professor of Medicine
Creighton University School of Medicine
Omaha, Nebraska

Target Audience

This activity is designed for health-system pharmacists.

Learning Objectives

  • Describe the clinical and economic burden of surgical bleeding in the United States, including the impact of blood transfusions
  • Outline the safety, efficacy, and pharmacoeconomics of biologic hemostatic agents
  • Implement hemostatic treatment protocols that effectively achieve hemostasis and ensure efficient healthcare resource use

Activity Overview

This on-demand webcast is available with synchronized slides and video.

To be eligible for documentation of credit, participants must participate in the full activity, complete the 10-question online post-test with a score of 70% or better, and complete the evaluation form. After successful completion of the post-test and evaluation form online at www.naccme.com, participants may immediately print their documentation of credit.

There is no fee associated with this activity.

Participants who have successfully completed the live version of this activity are not eligible to receive credit for this enduring material.

Release Date: November 24, 2009

Expiration Date: November 24, 2010  

Estimated time to complete: 1 hour

For questions regarding this activity, please call 609-371-1137.

 Hardware/Software Requirements

All educational activities are accessible via a computer with 650 MHz PC, 128 MB RAM, Windows or MAC operating system, Internet Explorer, Netscape, or Safari browsers. Windows Media Player, sound card, and speakers are required for streamed audio. Flash Player, sound card, and speakers are required for video programs. A PDF reader is required for print publications. Please direct technical questions to webmaster@naccme.com.

CPE Accreditation

North American Center for Continuing Medical Education, LLC (NACCME) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This activity is approved for 1 contact hour (0.1 CEU) of continuing pharmacy education (UAN 276-000-09-002-H01-P).

Any participant wanting to file a grievance with respect to any aspect of a continuing pharmacy education activity accredited by NACCME may contact John Savage, Director, Medical Education, NACCME, in writing at 300 Rike Drive, Suite A, Millstone Township, NJ 08535, or by e-mail at jsavage@naccme.com. The Director of Medical Education will review the grievance and respond within 30 days of receiving the written statement. If the participant is unsatisfied with the response, an appeal to the Vice President, Medical Education, NACCME, may be made for a second level of review.

This educational activity is a knowledge-based activity.

Independent Clinical Reviewer: Wendy Cantrell, PharmD, BCPS, BCNSP, CACP, Cardiology Clinical Specialist, University Medical Center of Southern Nevada, University of Southern Nevada College of Pharmacy, Las Vegas, Nevada

Planning Committee

The planning committee comprises Bradley A. Boucher, PharmD, FCCP, FCCM, BCPS, Wendy Cantrell, PharmD, BCPS, BCNSP, CACP, Mark A. Malesker, PharmD, FCCP, BCPS; Kristin Dickie, Mary Johnson, Michael Kearney, Rich Keenan, Nick Lombardi, Erin Phelps, Randy Robbin, John Savage, and Jessica Steuerman, NACCME.

Financial Disclosure and Conflicts of Interest  

According to the disclosure policy of NACCME, faculty, editors, managers, and other individuals who are in a position to control content are required to disclose any relevant financial relationships with relevant commercial companies related to this activity. All relevant conflicts of interest that are identified are reviewed for potential conflicts of interest. If a conflict is identified, it is the responsibility of NACCME to initiate a mechanism to resolve the conflict(s). The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation.
                
All educational materials are reviewed for fair balance, scientific objectivity of studies reported, and levels of evidence.
The faculty has reported the following:
Dr. Boucher: Consultant—Astellas Pharma US, Inc, Novo Nordisk, The Medicines Company; Promotional speakers bureau—ZymoGenetics, Inc
Dr. Malesker: Grant/research support—Bayer Pharmaceuticals, Bristol-Myers Squibb, GlaxoSmithKline, IntelliDx, Pfizer, Inc, Pneuma Pharmaceuticals, Wyeth Pharmaceuticals; Consultant—Arca Biopharma, sanofi-aventis U.S., ZymoGenetics, Inc; Promotional speakers bureau—sanofi-aventis U.S., ZymoGenetics, Inc
Dr. Cantrell has disclosed no relevant financial relationships with any commercial interests.

Ms. Dickie, Ms. Johnson, Mr. Kearney, Mr. Keenan, Mr. Lombardi, Ms. Phelps, Mr. Robbin, Mr. Savage, and Ms. Steuerman have disclosed no relevant financial relationships with any commercial interests.

NACCME requires faculty to inform participants whenever off-label/unapproved uses of drugs and/or devices are discussed in their presentations.

The faculty has disclosed that no off-label/unapproved use(s) of drugs and/or devices will be discussed.

Privacy Policy

NACCME protects the privacy of personal and other information regarding participants, educational partners, and joint sponsors. NACCME and our joint sponsors will not release personally identifiable information to a third party without the individual's consent, except such information as is required for reporting purposes to the appropriate accrediting agency.

NACCME maintains physical, electronic and procedural safeguards that comply with federal regulations to guard your nonpublic personal information.

Copyright © 2009 by North American Center for Continuing Medical Education, LLC. All rights reserved. No part of this accredited continuing education activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from North American Center for Continuing Medical Education.

Grant Support

Supported by an educational grant from ZymoGenetics, Inc.

Program Components

Introduction

Webcast

Post-Test



   

©Copyright 2003-2010 NACCME   Privacy Policy
Hardware/Software Requirements Disclosure Statement